mesalamine has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Din, H | 1 |
Anderson, AJ | 1 |
Ramos Rivers, C | 1 |
Proksell, S | 1 |
Koutroumpakis, F | 1 |
Salim, T | 1 |
Babichenko, D | 1 |
Tang, G | 1 |
Koutroubakis, IE | 1 |
Schwartz, M | 1 |
Johnston, E | 1 |
Barrie, A | 1 |
Harrison, J | 1 |
Hashash, J | 1 |
Dunn, MA | 1 |
Hartman, DJ | 1 |
Binion, DG | 1 |
1 other study available for mesalamine and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Disease Characteristics and Severity in Patients With Inflammatory Bowel Disease With Coexistent Diabetes Mellitus.
Topics: Adult; Aged; Biological Products; Colitis, Ulcerative; Crohn Disease; Diabetes Mellitus, Type 1; Dia | 2020 |